Related Experiment Video
Updated: Feb 15, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Opportunities and challenges of large-scale screening for atrial fibrillation
Matthias Daniel Zink1,2, Nikolaus Marx2, Harry J G M Crijns3
1Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands.
Insights
Large-scale screening for atrial fibrillation (AF) is now feasible due to advances in ECG diagnosis and anticoagulation. Further research is needed to determine optimal screening strategies and patient-specific treatments for AF.
Area of Science:
- Cardiology
- Medical Technology
- Public Health
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia linked to significant stroke and cardiovascular risks.
- Subclinical AF (SCAF) episodes are common, necessitating large-scale screening for effective stroke prevention.
- Emerging single-lead ECG devices show promise for SCAF diagnosis.
Purpose of the Study:
- To review recent advancements in AF screening and management.
- To focus on community-based screening using single-lead ECG and discontinuous monitoring.
- To discuss the implications for cost-effective patient treatment strategies.
Main Methods:
- Review of recent research on AF diagnosis and treatment.
- Focus on single-lead ECG technology for SCAF detection.
- Analysis of anticoagulation therapy efficacy and safety in AF patients.
Main Results:
- Progress in ECG technology and anticoagulation therapy supports large-scale AF screening.
- Non-vitamin K antagonist drugs are safe and effective for AF treatment.
- Current research highlights the potential of community-based, discontinuous screening approaches.
Conclusions:
- Advancements in diagnostics and therapeutics pave the way for widespread AF screening.
- Key questions remain regarding patient selection for screening and individualized treatment protocols.
- Further investigation is required to optimize AF management for improved patient outcomes and cost-effectiveness.
Abstract:
Atrial fibrillation (AF) is a common arrhythmia and is highly associated with stroke and cardiovascular morbidity. As many AF episodes remain subclinical (SCAF), large-scale AF screening is considered a desirable approach for the treatment and prevention of cardioembolic stroke. Newly available single-lead ECG devices have provided promising results in the diagnosis of SCAF and treatment by nonvitamin K antagonist drugs appears to be safe and effective. Nevertheless, a further gain in knowledge is needed to clarify the different types of AF. This may help to define how or if a patient should be treated in the context of outcome and cost effectiveness. This review summarizes the results of recent research in this field and focuses on single-lead, discontinuous single time-point, community-based comprehensive-screening-based AF management. We want to conclude that progress in ECG diagnosis and anticoagulation therapy has prepared the ground to establish large-scale AF screening. The remaining question, however, is which patients should be screened and what therapy should be initiated in case of AF.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
pH Scale
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Scaling
Thermometers and Temperature Scales
As many physical properties depend on temperature, the variety of thermometers is...

